Log in or Sign up for Free to view tailored content for your specialty!
ADD/ADHD News
Prescription digital therapy to treat ADHD appears feasible
A study found statistically significant improvement in ADHD symptoms in children who wore the Revibe Connect device to school, according to a press release.
Maternal eating disorders increase risk for ADHD, autism spectrum disorders in offspring
Children born to mothers with active eating disorders during pregnancy demonstrated an elevated risk for developing ADHD and autism spectrum disorders, according to a Swedish population-based cohort study published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
Mental disorders remain significant global burden on health
The prevalence of mental disorders has been on the rise and remains a significant leading cause of disease burden worldwide, according to a 30-year global systematic analysis published in The Lancet Psychiatry.
Diagnoses of neurodevelopmental disorders higher in publicly insured US children
Timing of and risk for childhood neurodevelopment disorder diagnoses is linked to various socioeconomic factors including insurance enrollment, according to a U.S. population-based cohort study published in JAMA Psychiatry.
Pharma company, global service provider partner to develop neuroscience disorder therapies
Neuroscience specialty pharmaceutical company OWP Pharmaceuticals Inc. has partnered with Eversana, a provider of global services to the life sciences industry, to launch oral liquid formulations for treating neuroscience disorders.
More screen time during COVID-19 pandemic has negative effects on pediatric mental health
Children and youth with more screen time had increased risk for poor mental health during the COVID-19 pandemic, according to results of a longitudinal cohort study conducted in Canada and published in JAMA Network Open.
Neurodevelopmental disorders, self-harm increase risk for school absence
The presence of neurodevelopmental or mental disorders or self-harm before age 24 years increased risk for missing school, according to results of a nationwide, retrospective, electronic cohort study.
Azstarys outperforms placebo for improving ADHD symptoms in children
Azstarys significantly improved ADHD symptoms in children aged 6 to 12 years vs. placebo, according to results of a randomized, controlled laboratory classroom study published in Journal of Child and Adolescent Psychopharmacology.
VIDEO: Azstarys offers ‘another tool in our toolbox’ for ADHD
Ann Childress, MD, president of the Center for Psychiatry and Behavioral Medicine Inc., discussed ADHD data from a poster presented at the American Psychiatric Nurses Association Annual Conference in a video interview with Healio.
Active, exuberant play helps infants develop cognitive, social skills
How infants spontaneously play in their daily environments may help them develop everyday learning faculties and grow cognitive, social and language abilities, according to a study published in Child Development.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read